BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 20855151)

  • 1. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
    Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
    Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
    Kim SO; Kim MR
    Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RKIp inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix.
    Xinzhou H; Ning Y; Ou W; Xiaodan L; Fumin Y; Huitu L; Wei Z
    Mol Biol (Mosk); 2011; 45(6):1004-11. PubMed ID: 22295570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Raf kinase inhibitor protein in rheumatoid fibroblast-like synoviocytes invasiveness and cytokine and matrix metalloproteinase expression.
    Ahn JK; Hwang JW; Bae EK; Lee J; Jeon CH; Koh EM; Cha HS
    Inflammation; 2012 Apr; 35(2):474-83. PubMed ID: 21556737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro.
    Hao C; Wei S; Tong Z; Li S; Shi Y; Wang X; Zhu ZH
    Tumour Biol; 2012 Aug; 33(4):1159-67. PubMed ID: 22373584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
    Lei X; Chang L; Ye W; Jiang C; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
    Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H
    Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
    Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
    PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of RKIP on proliferation and migration of malignant melanoma cells and potential mechanism].
    Zhou K; Zhang YY; Cen Y; Zhu GN; Zhang YG
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):616-621. PubMed ID: 30818932
    [No Abstract]   [Full Text] [Related]  

  • 11. RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex.
    Tang H; Park S; Sun SC; Trumbly R; Ren G; Tsung E; Yeung KC
    FEBS Lett; 2010 Feb; 584(4):662-8. PubMed ID: 20043910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
    Poudel B; Lee YM; Kim DK
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
    Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
    Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
    Philip S; Bulbule A; Kundu GC
    J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
    Li X; Tai HH
    Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Over-expression of Raf kinase inhibitor protein (RKIP) inhibits the proliferation of LX-2 human hepatic stellate cells].
    Nie J; Huang Q; Tan S; Lin X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1491-1494. PubMed ID: 27774941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs.
    Wu K; Bonavida B
    Crit Rev Immunol; 2009; 29(3):241-54. PubMed ID: 19538137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis.
    Huang Q; Wei J; Wei L; Zhang X; Bai F; Wen S; Wei Y; Tan S; Lu Z; Lin X
    J Cell Biochem; 2019 Apr; 120(4):6168-6177. PubMed ID: 30304566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
    Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH
    J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
    Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
    Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.